Factors which interact with oncoproteins
US6204253A · kind A · utility
3Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 1999 |
| Grant date | Mar 20, 2001 |
| Priority date | — |
| Expiry date | Mar 26, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57484
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to polypeptides that bind to the oncogene product mdm2 and the uses of the identified polypeptides in therapeutic compositions to treat aberrant cell division in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.